Insulin Delivery Device Market to Register Incremental Growth During the Forecast Period 2026 | Key Companies include Novo Nordisk, Ypsomed, Medtronic, Sanofi, Biocon, Eli Lilly, Abbott and Others

September 09 21:56 2021
Insulin Delivery Device Market to Register Incremental Growth During the Forecast Period 2026 | Key Companies include Novo Nordisk, Ypsomed, Medtronic, Sanofi, Biocon, Eli Lilly, Abbott and Others
Delveinsight Business Research LLP
DelveInsight’s latest report on “Insulin Delivery Device Market Insights, Competitive Landscape, and Market Forecast 2026” report covers an in-depth understanding of the historical & forecasted Insulin Delivery Device market trends and shares in the seven major markets (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

The Insulin Delivery Device market report provides an overview of the products, advantages, limitations, market share of the devices, current and forecasted market size from 2018 to 2026. The report also analyzed the market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Insulin Delivery Device Market Overview

Insulin, a hormone that controls blood sugar, plays a crucial function in diabetic therapy. As a result of its absolute deficiency, all patients with type 1 diabetes mellitus require insulin. With overall survival in patients with type 2, they will need insulin due to gradual β-cell loss. 

Insulin delivery devices assist in the secretion of insulin under the skin into the fatty tissue. It is also known that obesity is a significant cause contributing to the growth of diabetes in persons. Addressing these hurdles with innovative and efficient insulin delivery systems is thus necessary in order to prevent diabetes-related complications.

Insulin Delivery Device Market Segmentation

By Type

  • Insulin Pens
  • Insulin Pumps
  • Jet Injectors
  • Insulin Syringes


By End-User

  • Patients/Homecare
  • Hospitals & Clinics


Explore more about the recent developments in the market @ Insulin Delivery Device Market Trends and Growth Analysis

Key Highlights of the Insulin Delivery Device Market Report

  • The report covers the Insulin Delivery Device market outlook across 7MM and evaluates how the market is expected to rise during the study period (2018 to 2026) and at what CAGR.
  • Additionally, it analyses the Insulin Delivery Device market trends, drivers, barriers, future opportunities, and regulatory milestones. 
  • The report also provides a competitive analysis of the Insulin Delivery Device market. The competitive analysis will help to understand the competition in the market and of the products. 
  • The report provides a descriptive overview of the Insulin Delivery Device, explaining its applications, advantages, and limitations, etc. It takes account of the currently available products as well as the emerging products, the ongoing development activities that will have an impact on the future market growth.
  • A detailed review of the Insulin Delivery Device market including the historical and forecasted market size and devices outreach in the 7MM.

Overall, the report will provide an edge while formulating business strategies by understanding the latest developments, changing market dynamics, and key trends driving and shaping market growth.

Insulin Delivery Device Report Assessment

  • Marketed Product profiles
  • Key Products
  • Prominent Companies
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Insulin Delivery Device Market Drivers

  • Rising number of diabetes population due to aging, obesity, and unhealthy lifestyles
  • Higher healthcare spending in emerging countries
  • Technological advancement in the field of insulin delivery.

Insulin Delivery Device Market Barriers

  • Strict regulatory legislation and regulations regulating the medication approval process
  • The high cost of insulin analogs in the management of diabetes treatment

Key Companies in the Insulin Delivery Device Market

  • Becton
  • Dickinson and Company
  • Novo Nordisk
  • Ypsomed Holding
  • Medtronic
  • Animas Corporation
  • Tandem Diabetes Care
  • Sanofi
  • Biocon 
  • Eli Lilly and Company
  • Insulet Corporation.
  • Abbott
  • F. Hoffmann-La Roche 

Visit to know more about the leading player @ Insulin Delivery Device Key Companies and Product Profile

Table of Contents

1. Key Insights

2. Executive Summary of Insulin Delivery Device

3. Insulin Delivery Device: Background and Overview

3.1. Introduction

3.2. Types of Insulin Delivery Device

3.3. Advantages of Insulin Delivery Device

3.4. Disadvantages of Insulin Delivery Device

4. Insulin Delivery Device: Regulatory Scenario

5. Insulin Delivery Device: Reimbursement Scenario

6. Company Profiles

6.1 Company Overview

6.2 Product Portfolio

6.3 Product description

6.4 Regulatory Milestones

6.5 Research and Development

6.6 Product Development Activities

7. Insulin Delivery Device Competitive Analysis

8. KOL Views on Insulin Delivery Device Market

9. Insulin Delivery Device Market Analysis in 7MM 

10. Country-Wise Market size of Insulin Delivery Device

11. Insulin Delivery Device Market Dynamic (Drivers and Barriers)

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Visit to know more about the report offerings @

Latest Reports By DelveInsight:

Nicotine Addiction Market

DelveInsight’s “Nicotine Addiction Market Insights, Epidemiology and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Nicotine Addiction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Trending Healthcare Blog:

Phenylketonuria Market Outlook

Even though rare, Phenylketonuria carries a tremendous healthcare burden and leads to severe intellectual disability in cases of a lack of proper treatment. Currently, the condition is majorly treated with modifications and restrictions in diet to limit the intake of phenylalanine.  To overcome the existing unmet therapeutics demand, several pharmaceutical companies such as PTC Therapeutics, Homology Medicines, Synlogic, BioMarin Pharmaceutical among others are developing novel pipeline therapies. The launch of the emerging therapies in the coming years is expected to improve the treatment outlook and the life of the affected person. Read more: Phenylketonuria Therapy Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States